Ors as well as the injectable glucagonlike peptide1 (GLP1) receptor agonists, have shown
Ors along with the injectable glucagonlike peptide1 (GLP1) receptor agonists, have shown improvements in glycaemic values when added to metformin in patients with T2DM . GLP1 receptor agonists are related…